All In MedTech

Device Trial Radar · NCT07483008

3D Printing Technology For Planning Left Atrial Appendage Occlusion

3D Printing Technology For Planning Left Atrial Appendage Occlusion: A Randomised Trial

Last checked: Nov 20, 2026Latest source record: Mar 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 184 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

184

Actual

Start

Oct 1, 2017

Primary completion

Jan 31, 2022

Study completion Jan 31, 2022

Sponsor

Lead sponsor
Chinese University of Hong KongAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
The University of Hong Kong
First posted
Mar 19, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Atrial fibrillation is the most common cardiac arrhythmia, affecting 8.5% of the general population in Hong Kong. Systemic embolization, and particularly stroke, is the most frequent major complication of atrial fibrillation. Long-term oral anticoagulation is recommended for most atrial fibrillation patients for prevention of embolism. However, such therapy is associated with an increased risk of bleeding and not all individuals are candidates for this therapy. The left atrial appendage (LAA) is the usual source for clot that embolizes. Occlusion of the LAA ostium (LAAO) with percutaneous device in patients with nonvalvular atrial fibrillation has emerged as an alternative to anticoagulation for prevention of embolism. Procedural success requires careful planning and understanding of the anatomy of LAA, as well as the interaction between the appendage and the occlusion device. However, complexity and variability of LAA anatomy exists and these anatomical variations among individuals poses challenges to accurately sizing and positioning the device. Certain anatomic variations of the appendage, for instance the presence of a sharp bend in the proximal or middle portion of the dominant lobe, or prominent pectinate muscles, pose particular challenge to device implantation and demands pre-specified implantation technique. Assessment of LAA anatomy relies on imaging, usually combining peri-interventional 2D transesophageal echocardiography (TEE) with fluoroscopy guidance and, less frequently, with pre-interventional computed tomography (CT). Because lobes of the LAA exist in different planes, imaging must be done in multiple planes to visualize the entire LAA. Even with advanced imaging, complete understanding the 3D geometry of the appendage is challenging, and the mechanical interaction between the device and the anatomy is difficult to predict or quantify. The limitation of imaging in the assessment of LAA anatomy may lead to inaccurate device sizing. Over- or under-sizing increase the chance of pericardial effusion, incomplete occlusion, and device embolization. Incomplete occlusion of the LAA ostium is common and may jeopardise the procedural efficacy in embolism prevention. Device re-sizing during procedure prolongs procedural time as well as radiation exposure; moreover, device re-positioning within the appendage may cause inadvertent tissue injury and increase the risk of cardiac perforation. Indeed, procedural complication rate of LAAO remains fairly high in real-world practice. 3D printing (3DP) is a novel technology able to create a patient-specific model of any given anatomical portion of the heart for preoperative device testing and procedural simulation. The simulation "rehearsal" experience can enhance the operator's confidence, allowing the operator to anticipate difficulties before the actual intervention; this potentially reduces the procedural time (hence cost and radiation hazard), device re-sizing, the number of deployment attempts, and promotes procedural success. The aim of this project is to evaluate the effect of 3D-printed patient-specific LAA model compared with standard imaging planning on procedural efficacy and safety of LAAO. The project will be divided into two parts: Part I Technical validation of 3D-printed LAA models Validation of anatomical accuracy and material properties of the 3D-printed LAA model will be conducted in 30 patients referred for clinically indicated surgical excision of the LAA. Part II Randomised clinical trial on additive benefit of 3D printing for LAAO. The investigators will conduct a randomized, controlled, open-label, trial in 200 patients undergoing LAAO for stroke prevention in our hospital. Eligible subjects will be randomly assigned by a computer program in a 1:1 ratio to either preoperative planning using 3D-printed LAA model (3D printing arm) or standard imaging planning alone (no-3D printing arm). The investigators hypothesize that preoperative 3DP planning could help in finding the correct position within LAA, sizing the device and guiding the choice of the closure device despite the measurements provided by imaging alone.

Conditions

  • Atrial Fibrillation (AF)
  • 3D Printing
  • Cost Benefit Analysis

Interventions

  • 3D-printed models of the left atrial appendageDevice

    Participants receive preoperative planning using patient-specific 3D-printed models of the left atrial appendage. This arm includes procedural simulation with different occlusion devices and sizes to optimize the intervention.

  • Standard preoperative planningOther

    Participants undergo standard preoperative planning based solely on traditional imaging techniques, such as 2D/3D transesophageal echocardiography (TEE) and optionally computed tomography (CT).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To assess the rate of complete occlusion of the ostiumTime frame: The occlusion rate will be assessed during the procedure and at the 45-day TEE follow-up

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Division of Cardiology, Department of Medicine and Therapeutics Faculty of Medicine, The Chinese University of Hong Kong

    Hong Kong, New Territories, Hong Kong

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.